Publication | Closed Access

Low-Dose Rabbit Antithymocyte Globulin Versus Basiliximab Induction Therapy in Low-Risk Renal Transplant Recipients: 8-Year Follow-Up

UrologyTransplantationKidney TransplantKidney Transplantation8-Year Follow-upHematologyImmunologyTransplantation MedicineGraft SurvivalMedicineNephrologyGraft Rejection